Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.

Martinez-Martin, F J

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study. [electronic resource] - Journal of human hypertension Jun 2011 - 346-53 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1476-5527

10.1038/jhh.2010.104 doi


Adiponectin--blood
Adult
Aged
Amlodipine--pharmacology
Antihypertensive Agents--pharmacology
Blood Pressure--drug effects
C-Reactive Protein--metabolism
Comorbidity
Cytokines--blood
Diabetes Mellitus, Type 2
Drug Therapy, Combination
Female
Humans
Hydrochlorothiazide--pharmacology
Hypertension--blood
Imidazoles--pharmacology
Incidence
Insulin Resistance--physiology
Intercellular Adhesion Molecule-1--blood
Male
Metabolic Syndrome--blood
Middle Aged
Prospective Studies
Single-Blind Method
Tetrazoles--pharmacology
Treatment Outcome
Vascular Cell Adhesion Molecule-1--blood